Back to EG Engineers Gate Manager LP
QNCX
5 quarters
Position history for EGEngineers Gate Manager LP's holdings in QUINCE THERAPEUTICS INC
No. Engineers Gate exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 12,193 shares worth $40,847. Engineers Gate first reported QNCX in Q4 2021 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$143,000
Total Shares Change
-11,332
Quarter-by-Quarter History
Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors